ANTREP HEALTHCARE SOLUTIONS
News & Events
Scientific Evidence & Global Guidelines
American Cancer Society (ACS)
Relevance: General population screening guidance with strong FIT recommendation.
Source: Cancer.org
Visit source
US Preventive Services Task Force (USPSTF)
Relevance: FIT / HS-gFOBT recommended as annual stool-based screening methods.
Source: USPSTF
Visit Source
US Multi-Society Task Force (USMSTF)
Relevance: FIT + colonoscopy listed as first-tier screening options with defined intervals.
Source: PubMed
Visit Source
ASGE — FIT Review
Relevance: Superior sensitivity and technical advantages over guaiac FOBT.
Source: ASGE.org
Visit Source
MDPI (2024) — CRC Screening Review
Relevance: Detailed evaluation of stool-based screening tests including FIT.
Source: MDPI
Visit Source
JAMA Network (2024)
Relevance: Real-world data showing reduced CRC mortality with routine FIT testing.
Source: JAMA Network
Visit Source
International Guidelines Supporting FIT Screening
World Health Organization (WHO)
Supports: Population-based CRC screening using FIT/FOBT.
Recognizes FIT as an effective non-invasive public-health screening tool.
NCCN (USA)
Recommends: FIT annually for average-risk adults ≥45 years.
Positive FIT → colonoscopy. FIT recognized as evidence-based & cost-effective.
ESGE (Europe)
Endorses: FIT for large-scale CRC screening; preferred over guaiac FOBT.
Supports centralized population FIT programs.
NICE (United Kingdom)
Recommends: FIT for symptomatic patients in primary care.
Used for triage and colonoscopy referral prioritization.
ICMR / MoHFW (India)
Position: FIT advised for community-level & population-based screening programs.
Recognizes need for scalable, low-cost CRC screening solutions.